Guidelines for transfusion support in patients undergoing coronary artery bypass grafting

Lawrence Tim Goodnough, Marilyn F M Johnston, Glenn Ramsey, Merlin H. Sayers, Richard S. Eisenstadt, Kenneth C. Anderson, Roanne C. Rutman, Les E. Silberstein

Research output: Contribution to journalArticle

90 Citations (Scopus)

Abstract

We have reviewed the impact of evolving issues in coronary artery bypass grafting (CABG) on transfusion support for these patients. Issues include increased awareness of transfusion risks, reappraisal of traditional indicators triggering transfusion, and evolving alternatives to homologous blood transfusion such as autologous blood and pharmacologic therapy. These issues have been prompted by programs, such as the National Institutes of Health Consensus Conferences, to provide physicians with guidelines for appropriate use of blood components. However, evidence suggests that transfusion practice in coronary artery bypass grafting procedures remains variable and does not take into account the results of recently published clinical studies. We have therefore developed guidelines and recommendations for transfusion support in patients undergoing coronary artery bypass grafting. In summary, they are the following. 1. 1. Institutions with coronary artery bypass grafting programs should establish a multidisciplinary approach to use a combination of interventions designed to minimize homologous blood exposure. 2. 2. Prophylactic transfusion of plasma and platelets are of no benefit and therefore carry an unnecessary risk to the patient. 3. 3. Special request products such as designated blood donation from first-degree relatives should not be used because of the risk of transfusion-associated graft versus host disease. 4. 4. For support of intravascular volume, crystalloids or colloids should be used because they do not have the potential to transmit infection.

Original languageEnglish (US)
Pages (from-to)675-683
Number of pages9
JournalThe Annals of Thoracic Surgery
Volume50
Issue number4
DOIs
StatePublished - 1990

Fingerprint

Coronary Artery Bypass
Guidelines
Platelet Transfusion
National Institutes of Health (U.S.)
Colloids
Graft vs Host Disease
Blood Donors
Blood Transfusion
Consensus
Physicians
Infection
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Goodnough, L. T., Johnston, M. F. M., Ramsey, G., Sayers, M. H., Eisenstadt, R. S., Anderson, K. C., ... Silberstein, L. E. (1990). Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. The Annals of Thoracic Surgery, 50(4), 675-683. https://doi.org/10.1016/0003-4975(90)90221-Q

Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. / Goodnough, Lawrence Tim; Johnston, Marilyn F M; Ramsey, Glenn; Sayers, Merlin H.; Eisenstadt, Richard S.; Anderson, Kenneth C.; Rutman, Roanne C.; Silberstein, Les E.

In: The Annals of Thoracic Surgery, Vol. 50, No. 4, 1990, p. 675-683.

Research output: Contribution to journalArticle

Goodnough, LT, Johnston, MFM, Ramsey, G, Sayers, MH, Eisenstadt, RS, Anderson, KC, Rutman, RC & Silberstein, LE 1990, 'Guidelines for transfusion support in patients undergoing coronary artery bypass grafting', The Annals of Thoracic Surgery, vol. 50, no. 4, pp. 675-683. https://doi.org/10.1016/0003-4975(90)90221-Q
Goodnough, Lawrence Tim ; Johnston, Marilyn F M ; Ramsey, Glenn ; Sayers, Merlin H. ; Eisenstadt, Richard S. ; Anderson, Kenneth C. ; Rutman, Roanne C. ; Silberstein, Les E. / Guidelines for transfusion support in patients undergoing coronary artery bypass grafting. In: The Annals of Thoracic Surgery. 1990 ; Vol. 50, No. 4. pp. 675-683.
@article{b69e05f6897e4aa896df9516bf4e0111,
title = "Guidelines for transfusion support in patients undergoing coronary artery bypass grafting",
abstract = "We have reviewed the impact of evolving issues in coronary artery bypass grafting (CABG) on transfusion support for these patients. Issues include increased awareness of transfusion risks, reappraisal of traditional indicators triggering transfusion, and evolving alternatives to homologous blood transfusion such as autologous blood and pharmacologic therapy. These issues have been prompted by programs, such as the National Institutes of Health Consensus Conferences, to provide physicians with guidelines for appropriate use of blood components. However, evidence suggests that transfusion practice in coronary artery bypass grafting procedures remains variable and does not take into account the results of recently published clinical studies. We have therefore developed guidelines and recommendations for transfusion support in patients undergoing coronary artery bypass grafting. In summary, they are the following. 1. 1. Institutions with coronary artery bypass grafting programs should establish a multidisciplinary approach to use a combination of interventions designed to minimize homologous blood exposure. 2. 2. Prophylactic transfusion of plasma and platelets are of no benefit and therefore carry an unnecessary risk to the patient. 3. 3. Special request products such as designated blood donation from first-degree relatives should not be used because of the risk of transfusion-associated graft versus host disease. 4. 4. For support of intravascular volume, crystalloids or colloids should be used because they do not have the potential to transmit infection.",
author = "Goodnough, {Lawrence Tim} and Johnston, {Marilyn F M} and Glenn Ramsey and Sayers, {Merlin H.} and Eisenstadt, {Richard S.} and Anderson, {Kenneth C.} and Rutman, {Roanne C.} and Silberstein, {Les E.}",
year = "1990",
doi = "10.1016/0003-4975(90)90221-Q",
language = "English (US)",
volume = "50",
pages = "675--683",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Guidelines for transfusion support in patients undergoing coronary artery bypass grafting

AU - Goodnough, Lawrence Tim

AU - Johnston, Marilyn F M

AU - Ramsey, Glenn

AU - Sayers, Merlin H.

AU - Eisenstadt, Richard S.

AU - Anderson, Kenneth C.

AU - Rutman, Roanne C.

AU - Silberstein, Les E.

PY - 1990

Y1 - 1990

N2 - We have reviewed the impact of evolving issues in coronary artery bypass grafting (CABG) on transfusion support for these patients. Issues include increased awareness of transfusion risks, reappraisal of traditional indicators triggering transfusion, and evolving alternatives to homologous blood transfusion such as autologous blood and pharmacologic therapy. These issues have been prompted by programs, such as the National Institutes of Health Consensus Conferences, to provide physicians with guidelines for appropriate use of blood components. However, evidence suggests that transfusion practice in coronary artery bypass grafting procedures remains variable and does not take into account the results of recently published clinical studies. We have therefore developed guidelines and recommendations for transfusion support in patients undergoing coronary artery bypass grafting. In summary, they are the following. 1. 1. Institutions with coronary artery bypass grafting programs should establish a multidisciplinary approach to use a combination of interventions designed to minimize homologous blood exposure. 2. 2. Prophylactic transfusion of plasma and platelets are of no benefit and therefore carry an unnecessary risk to the patient. 3. 3. Special request products such as designated blood donation from first-degree relatives should not be used because of the risk of transfusion-associated graft versus host disease. 4. 4. For support of intravascular volume, crystalloids or colloids should be used because they do not have the potential to transmit infection.

AB - We have reviewed the impact of evolving issues in coronary artery bypass grafting (CABG) on transfusion support for these patients. Issues include increased awareness of transfusion risks, reappraisal of traditional indicators triggering transfusion, and evolving alternatives to homologous blood transfusion such as autologous blood and pharmacologic therapy. These issues have been prompted by programs, such as the National Institutes of Health Consensus Conferences, to provide physicians with guidelines for appropriate use of blood components. However, evidence suggests that transfusion practice in coronary artery bypass grafting procedures remains variable and does not take into account the results of recently published clinical studies. We have therefore developed guidelines and recommendations for transfusion support in patients undergoing coronary artery bypass grafting. In summary, they are the following. 1. 1. Institutions with coronary artery bypass grafting programs should establish a multidisciplinary approach to use a combination of interventions designed to minimize homologous blood exposure. 2. 2. Prophylactic transfusion of plasma and platelets are of no benefit and therefore carry an unnecessary risk to the patient. 3. 3. Special request products such as designated blood donation from first-degree relatives should not be used because of the risk of transfusion-associated graft versus host disease. 4. 4. For support of intravascular volume, crystalloids or colloids should be used because they do not have the potential to transmit infection.

UR - http://www.scopus.com/inward/record.url?scp=0025066309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025066309&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(90)90221-Q

DO - 10.1016/0003-4975(90)90221-Q

M3 - Article

C2 - 2222067

AN - SCOPUS:0025066309

VL - 50

SP - 675

EP - 683

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 4

ER -